Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Spectrum Pharmaceuticals, Inc.    SPPI   US84763A1088

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/20/2015 05/21/2015 05/22/2015 05/26/2015 05/27/2015 Date
6.39(c) 6.31(c) 6.34(c) 6.24(c) 6.24 Last
962 417 825 211 686 464 928 020 798 327 Volume
-1.69% -1.25% +0.48% -1.58% 0.00% Change
More quotes
Financials ($)
Sales 2015 135 M
EBIT 2015 -66,4 M
Net income 2015 -75,6 M
Debt 2015 -
Yield 2015 -
Sales 2016 152 M
EBIT 2016 -54,9 M
Net income 2016 -65,7 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 3,09x
Capi. / Sales 2016 2,74x
Capitalization 418 M
More Financials
Company
Spectrum Pharmaceuticals, Inc. engages in the development and manufacture of pharmaceutical products.The firm acquires, develops, and commercializes a pipeline of clinical and commercial products under the FUSILEV, FOLOTYN, ZEVALIN, MARQIBO, and BELEODAQ brands.It operates through the United States... 
More about the company
Surperformance© ratings of Spectrum Pharmaceuticals,
Trading Rating : Investor Rating :
More Ratings
Latest news on SPECTRUM PHARMACEUTICALS,
05/26 SPECTRUM PHARMACEUTICALS : Nuclear Regulatory Commission (NRC) (F.R. Page 18655)..
05/18 SPECTRUM PHARMACEUTICALS : Nuclear Regulatory Commission (NRC) (F.R. Page 18655)..
05/14 SPECTRUM PHARMACEUTICALS : Commits to Review Shareholder Proposal
05/12 SPECTRUM PHARMACEUTICALS : Reports First Quarter 2015 Financial Results
05/11 SPECTRUM PHARMACEUTICALS : Nuclear Regulatory Commission (NRC) (F.R. Page 18655)..
05/07 SPECTRUM PHARMACEUTICALS : Pharma reports 1Q loss
05/07 SPECTRUM PHARMACEUTICALS : Reports Continued Advancement of Robust, Late-Stage P..
05/07 SPECTRUM PHARMACEUTICALS : Results of Operations and Financial Condition, Financ..
More news
Sector news : Biotechnology & Medical Research - NEC
04:13p PUMA BIOTECHNOLOGY : to Present at Jefferies 2015 Healthcare Conference
07:31a INCYTE : Clinical Portfolio to be Featured in 23 Abstract Presentations at the 2..
05/26DJNew Push Ties Cost of Drugs to How Well They Work
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
05/18 SPECTRUM PHARMACEUTICALS : Our Thoughts On Armistice Capital's 13D
05/12 Midday Gainers / Losers
05/12 Premarket Gainers / Losers
05/08 Spectrum Pharma net loss improves in Q1
05/07 Spectrum Pharmaceuticals (SPPI) Q1 2015 Results - Earnings Call Webcast


Comments 
Advertisement
Chart SPECTRUM PHARMACEUTICALS,
Duration : Period :
Spectrum Pharmaceuticals,  Technical Analysis Chart | SPPI | US84763A1088 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions